[Chronic obstructive pulmonary disease and heart failure]. [electronic resource]
Producer: 20091116Description: 387-93 p. digitalISSN:- 1579-2129
- Adrenergic beta-Agonists -- adverse effects
- Adrenergic beta-Antagonists -- adverse effects
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Atrial Natriuretic Factor -- blood
- Biomarkers
- Bronchodilator Agents -- adverse effects
- C-Reactive Protein -- analysis
- Combined Modality Therapy
- Contraindications
- Drug Interactions
- Heart Failure -- blood
- Heart Function Tests
- Humans
- Hypertension, Pulmonary -- drug therapy
- Natriuretic Peptide, Brain -- blood
- Oxygen Inhalation Therapy
- Peptide Fragments -- blood
- Pulmonary Disease, Chronic Obstructive -- blood
- Pulmonary Heart Disease -- drug therapy
- Respiration, Artificial
- Respiratory Function Tests
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.